9/28/2014, Portenoy Opioid Talk Sparks Controversy


Sources within NIH have acknowledged that Portenoy’s presence at the workshop (titled “The Role of Opioids in Treating Chronic Pain”) may be seen as controversial — not least because of a 2012 Wall Street Journal article in which he admitted that he erred in overstating the benefits and diminishing the risks of opioid analgesics…

Andrew Kolodny, MD, a critic of opioids and president of Physicians for Responsible Opioid Prescribing, who will attend the meeting, noted that it was not the decision of the entire work group to invite Portenoy. “It is unfortunate that NIDA and the FDA invited someone with serious conflicts of interest,” Kolodny said…

Mr. Kolodny pointing out conflicts of interest for other people, with no mention of his own… that’s hilarious.

If you don't comment, I'll just assume you agree with me

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s